CA
NZ
UK
AU
IND
US
The Goldman Sachs Group, Inc. has issued $10,023,000 in principal amount of Callable Fixed Rate Notes due 2046, paying interest at 6.00% per annum. The notes were priced on July 16, 2026, with an original issue date of July 20, 2026, and will mature …
BofA Finance LLC, a subsidiary of Bank of America Corporation, announced the pricing of Buffered Digital Return Notes on July 20, 2026, offering investors exposure to the Nasdaq-100 and S&P 500 indexes with a built-in buffer against moderate market declines. The notes feature a …
JPMorgan Chase Financial Company LLC has priced $600,000 in principal amount of Auto Callable Contingent Interest Notes linked to the MerQube US Large-Cap Vol Advantage Index, with settlement expected on or about July 21, 2026. The structured investment offers investors contingent interest payments of …
Jefferies Financial Group Inc. has filed a preliminary pricing supplement for the issuance of Senior Autocallable Barrier Notes due August 5, 2031, linked to the worst-performing of three major U.S. equity indices. The notes, priced at $1,000 per note, feature an autocall feature with …
Jefferies Financial Group Inc. disclosed the pricing of Senior Autocallable Barrier Notes due August 5, 2031, linked to the worst-performing of the Dow Jones Industrial Average, Russell 2000 Index, and S&P 500 Index. The notes, issued at $1,000 per note, feature an autocall structure …
Morgan Stanley Finance LLC has issued Callable Contingent Income Securities due August 2, 2029, linked to the performance of the S&P 500 Index, the Regional Banking ETF, and the Technology Select Sector SPDR ETF. The securities offer a 12.40% annual contingent coupon but expose …
Citigroup Global Markets Holdings Inc. has announced a new offering of Medium-Term Senior Notes linked to Space Exploration Technologies Corp., featuring autocallable contingent coupon structures maturing in January 2028. The securities, issued by a Citigroup subsidiary and guaranteed by Citigroup Inc., offer investors the …
MapLight Therapeutics recently submitted a Form 4 that details insider share transactions, a disclosure that can shape market perception of the company and its peers. The filing indicates that executives or directors have either increased or decreased their holdings, an event that investors closely …
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has completed an equity sale, exchanging approximately $23 million in 2028 notes for common stock and cash. The exchange has removed the 2028 notes, providing Xeris Biopharma Holdings, Inc. with more flexibility for future growth.
Eli Lilly’s $3.8 billion acquisition of psychedelic drug maker Atai has delivered a decisive buy signal to the mental health sector, positioning psychedelics as a mainstream therapeutic frontier. The deal, one of the largest in the space, underscores Big Pharma’s pivot toward once-marginalized compounds …
Please wait processing your request...